8TH3
Structure of AT118-H Nanobody Antagonist in Complex with the Angiotensin II Type I Receptor
Summary for 8TH3
Entry DOI | 10.2210/pdb8th3/pdb |
EMDB information | 41248 41249 |
Descriptor | AT118-H nanobody, Type-1 angiotensin II receptor, Soluble cytochrome b562 complex, BAG2 Anti-BRIL Fab Heavy Chain, BAG2 Anti-BRIL Fab Light Chain, ... (4 entities in total) |
Functional Keywords | g protein-coupled receptor, nanobody, signaling protein-immune system complex, signaling protein/immune system |
Biological source | Camelidae More |
Total number of polymer chains | 4 |
Total formula weight | 179783.30 |
Authors | Skiba, M.A.,Kruse, A.C. (deposition date: 2023-07-13, release date: 2024-05-22, Last modification date: 2024-05-29) |
Primary citation | Skiba, M.A.,Sterling, S.M.,Rawson, S.,Zhang, S.,Xu, H.,Jiang, H.,Nemeth, G.R.,Gilman, M.S.A.,Hurley, J.D.,Shen, P.,Staus, D.P.,Kim, J.,McMahon, C.,Lehtinen, M.K.,Rockman, H.A.,Barth, P.,Wingler, L.M.,Kruse, A.C. Antibodies expand the scope of angiotensin receptor pharmacology. Nat.Chem.Biol., 2024 Cited by PubMed: 38744986DOI: 10.1038/s41589-024-01620-6 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3 Å) |
Structure validation
Download full validation report